The Investor Relations website contains information about Collegium Pharmaceutical Inc.'s business for stockholders, potential investors, and financial ...
The bid & ask refers to the price that an investor is willing to buy or sell a stock. ... Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
Christopher Shayne James M.D., Vice President of Investor Relations, --, --, --. Mr. Bart J. Dunn, Executive Vice President of Strategy & Corporate Development ...
COLL 8.3 Investor relations · Application · Drawing up and availability of a prospectus · False or misleading prospectus · Table: contents of qualified investor ...
Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for ...
Feb 22, 2024 · (NASDAQ:COLL) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET. Company Participants. Christopher James - VP of Investor Relations
Responsible for business development, consultant relations, and client relationship management for institutions in the US and internationally. Reported to CEO ...
People also ask
How do I contact Collegium Pharmaceuticals?
What does Collegium Pharmaceutical do?